Suppr超能文献

肿瘤免疫原性的分子见解

Molecular Insights into Tumor Immunogenicity.

作者信息

Doytchinova Irini, Sotirov Stanislav, Dimitrov Ivan

机构信息

Drug Design and Bioinformatics Lab, Faculty of Pharmacy, Medical University of Sofia, Dunav St. 2, 1000 Sofia, Bulgaria.

出版信息

Curr Issues Mol Biol. 2025 Aug 11;47(8):641. doi: 10.3390/cimb47080641.

Abstract

Tumor immunogenicity depends on the ability of peptides to form stable and specific interactions with both HLA molecules and T-cell receptors (TCRs). While HLA binding is essential, not all HLA-binding peptides elicit T-cell responses. This study investigates the molecular features distinguishing immunogenic T-cell epitopes from non-immunogenic HLA binders. Two datasets of nonamer peptides-38 T-cell epitopes and 144 non-epitopes-were compiled and analyzed using sequence logo models and molecular dynamics (MD) simulations of TCR-peptide-HLA complexes. A comparative logo analysis revealed strong amino acid preferences at central positions (p4-p8) in T-cell epitopes and absences in non-epitopes. A representative epitope-non-epitope pair was selected for structural modeling and 100 ns MD simulations. The T-cell epitope formed a more stable complex with the TCR and exhibited greater flexibility, supporting an induced-fit recognition mechanism. It also established a broader and longer-lasting network of hydrogen bonds and π interactions across the residues at positions p4-p8. In contrast, the non-epitope engaged TCR at only two positions. These findings highlight the critical role of the peptide's central region in TCR engagement and provide structural insights useful for neoantigen prediction, vaccine design, and TCR-based immunotherapies.

摘要

肿瘤免疫原性取决于肽段与人类白细胞抗原(HLA)分子和T细胞受体(TCR)形成稳定且特异性相互作用的能力。虽然HLA结合至关重要,但并非所有与HLA结合的肽段都会引发T细胞反应。本研究调查了区分免疫原性T细胞表位与非免疫原性HLA结合肽的分子特征。利用序列标识模型和TCR-肽段-HLA复合物的分子动力学(MD)模拟,编制并分析了九聚体肽段的两个数据集——38个T细胞表位和144个非表位。比较性的标识分析揭示了T细胞表位中心位置(p4-p8)存在强烈的氨基酸偏好,而非表位则没有。选择了一对具有代表性的表位-非表位进行结构建模和100纳秒的MD模拟。T细胞表位与TCR形成了更稳定的复合物,并表现出更大的灵活性,支持诱导契合识别机制。它还在p4-p8位置的残基间建立了更广泛、更持久的氢键和π相互作用网络。相比之下,非表位仅在两个位置与TCR结合。这些发现突出了肽段中心区域在TCR结合中的关键作用,并为新抗原预测、疫苗设计和基于TCR的免疫疗法提供了有用的结构见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d865/12384583/64acaef2e076/cimb-47-00641-g001.jpg

相似文献

1
Molecular Insights into Tumor Immunogenicity.
Curr Issues Mol Biol. 2025 Aug 11;47(8):641. doi: 10.3390/cimb47080641.
4
Design and immunogenic evaluation of multi-epitope vaccines for colorectal cancer: insights from molecular dynamics and studies.
Front Oncol. 2025 Jun 17;15:1592072. doi: 10.3389/fonc.2025.1592072. eCollection 2025.
5
Integrated system for screening tumor-specific TCRs, epitopes, and HLA subtypes using single-cell sequencing data.
J Immunother Cancer. 2025 Jul 31;13(7):e012029. doi: 10.1136/jitc-2025-012029.
7
An in vitro CD8 T-cell priming assay enables epitope selection for hepatitis C virus vaccines.
Vaccine. 2024 Sep 17;42(22):126032. doi: 10.1016/j.vaccine.2024.05.080. Epub 2024 Jul 3.
10
Design of High-Affinity gp100 Antigenic Mimotopes for Targeting Melanoma.
J Phys Chem B. 2025 Jul 31;129(30):7708-7718. doi: 10.1021/acs.jpcb.5c01507. Epub 2025 Jul 22.

本文引用的文献

1
Targeting peptide antigens using a multiallelic MHC I-binding system.
Nat Biotechnol. 2024 Dec 13. doi: 10.1038/s41587-024-02505-8.
2
The Immune Epitope Database (IEDB): 2024 update.
Nucleic Acids Res. 2025 Jan 6;53(D1):D436-D443. doi: 10.1093/nar/gkae1092.
4
Neoantigens in cancer immunotherapy: focusing on alternative splicing.
Front Immunol. 2024 Jul 11;15:1437774. doi: 10.3389/fimmu.2024.1437774. eCollection 2024.
6
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges.
Biomark Res. 2023 Dec 1;11(1):104. doi: 10.1186/s40364-023-00534-0.
9
TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex.
J Immunol. 2020 Apr 1;204(7):1943-1953. doi: 10.4049/jimmunol.1900915. Epub 2020 Feb 26.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验